Evidence map›Paper›PMID 40935904›Full record

ArticleMycopathologia2025

First Isolation of a Multi-azole-Resistant Aspergillus fumigatus cyp51A TR

Xiang Han, Heng Zhang, Yuqi Mao, Wenhao Ling, Lu Ge, Menghua Tang, Yi Sun, Zhiqin Wu

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiang HanDepartment of Ophthalmology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434100, Hubei Province, China.
Heng ZhangDepartment of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434100, Hubei Province, China.
Yuqi MaoDepartment of Ophthalmology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434100, Hubei Province, China.
Wenhao LingDepartment of Respiratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434100, Hubei Province, China.
Lu GeHealth Science Center, Yangtze University, Jingzhou, 434023, Hubei Province, China.
Menghua TangHealth Science Center, Yangtze University, Jingzhou, 434023, Hubei Province, China.
Yi SunDepartment of Dermatology, Hubei Provincial Clinical Research Center for Diagnosis and Therapeutics of Pathogenic Fungal Infection, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434100, Hubei Province, China.
Zhiqin WuDepartment of Ophthalmology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434100, Hubei Province, China. yts121@126.com.

Funding

Jingzhou Science and Technology Plan Project(CN) 2024HD34]Key Research and Development program of Hubei Province(CN) 2024BCB043Yangtze University Science and Technology Aid to Tibet Medical Talent Training Program Project(CN) 2023YZ06
6 · The paper itself

Abstract

introductionFungal keratitis (FK), a severe ocular infection caused primarily by Fusarium spp. and Aspergillus spp., remains a major cause of blindness worldwide. Current treatment relies on antifungal agents, though emerging azole resistance in Aspergillus fumigatus complicates therapeutic outcomes. MATERIALS AND

methodsWe isolated a clinical FK strain and assessed its antifungal susceptibility using broth microdilution and E-test methods, followed by sequencing of the cyp51A gene's promoter region and coding sequence (CDS) to identify resistance-associated mutations.

resultsThe isolate, confirmed as A. fumigatus (Aftr46-001) via ITS and β-tubulin sequencing, exhibited elevated minimum inhibitory concentrations (MICs) 16 µg/mL for itraconazole (ITC), 32 µg/mL for isavuconazole (ISA), 32 µg/mL for voriconazole (VRC), and 1 µg/mL for posaconazole (POS) by broth microdilution. E-test results revealed an ITR MIC of 12 µg/mL, ISA MIC 32 µg/mL, VRC MIC 32 µg/mL, and POS MIC of 2 µg/mL. The isolate exhibited MICs values at or above the CLSI and EUCAST epidemiological cutoff values (ECVs): 1 µg/mL for ITC, ISA, and VRC according to CLSI (with insufficient data to establish a POS ECV), and 1 µg/mL for ITC and VRC, 2 µg/mL for ISA, and 0.25 µg/mL POS per EUCAST criteria. Genotypic analysis identified a 46-nucleotide tandem repeat in the cyp51A promoter and two nonsynonymous mutations (Y46F, F70L). DISCUSSION: This represents the first report of a cyp51A TR46/Y46F/F70L-harboring A. fumigatus strain isolated from FK, with potential agricultural environmental origins, suggesting that this mutation may have become a potential driver of azole-resistant FK in areas with high agricultural exposure, urgently needing to be included in local treatment guidelines and active surveillance systems. The isolate's resistance to all tested azoles underscores the clinical challenge posed by this genotype. Following this combined intervention, the patient's left eye vision improved from counting fingers at 1 m upon admission to a final visual acuity of 0.3, indicating that combined surgery and local high-dose drug delivery can serve as an effective strategy for drug-resistant FK. These findings highlight the importance of monitoring azole-resistant A. fumigatus strains to guide clinical treatment. The global increase in azole drug resistance further highlights the urgency and importance of rapid and accurate pathogen identification and drug resistance testing in the current environment.

Indexed as

Antifungal AgentsAspergillus fumigatusAzolesCytochrome P-450 Enzyme SystemDrug Resistance, FungalDrug Resistance, Multiple, FungalKeratitisAspergillosisDNA, FungalDNA, Ribosomal SpacerFungal ProteinsHumansMaleMicrobial Sensitivity TestsPromoter Regions, GeneticSequence Analysis, DNAAntifungal AgentsAzolescytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemDNA, FungalDNA, Ribosomal SpacerFungal ProteinsA. fumigatusAntifungal susceptibilityAzole resistancecyp51A mutationFungal keratitisTR46/Y46F/F70L

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.